Skip to Content

Erelzi

In the US, Erelzi (etanercept systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis.

US matches:

UK matches:

Ingredient matches for Erelzi

Etanercept

Etanercept is reported as an ingredient of Erelzi in the following countries:

  • Canada
  • Estonia
  • Netherlands
  • Romania
  • Sweden
  • United Kingdom
  • United States

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide